United Kingdom · Question · Written question
HL HL2119
Blood Cancer: Coronavirus
Introduced
16 July 2021
Last action
23 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 July 2021
Summary
To ask Her Majesty's Government what plans they have to provide doses of monoclonal antibodies to people with blood cancer who have had the COVID-19 vaccine.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 July 2021
Written question
To ask Her Majesty's Government what plans they have to provide doses of monoclonal antibodies to people with blood cancer who have had the COVID-19 vaccine.
Source: Lords
23 July 2021
Answer
Immunocompromised patients are a priority cohort for research into therapeutic and prophylaxis treatments such as monoclonal antibody therapies, novel antivirals, and repurposed compounds. Monoclonal antibody treatments could potentially play a complement...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-16/HL2119
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1347835
- uk · wq-1347835 · source updated 23 July 2021